skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry

Journal Article · · Journal of Virology
DOI:https://doi.org/10.1128/jvi.00676-19· OSTI ID:1626071
 [1];  [2];  [2];  [1];  [2]
  1. Stony Brook Univ., NY (United States)
  2. State Univ. of New York (SUNY), Buffalo, NY (United States)

A key step in the Ebola virus (EBOV) replication cycle involves conformational changes in viral glycoprotein 2 (GP2) which facilitate host-viral membrane fusion and subsequent release of the viral genome. Ebola GP2 plays a critical role in virus entry and has similarities in mechanism and structure to the HIV gp41 protein for which inhibitors have been successfully developed. In this work, a putative binding pocket for the C-terminal heptad repeat in the N-terminal heptad repeat trimer was targeted for identification of small molecules that arrest EBOV-host membrane fusion. Two computational structure-based virtual screens of ~1.7 M compounds were performed (DOCK program) against a GP2 five-helix bundle, resulting in 165 commercially available compounds purchased for experimental testing. Based on assessment of inhibitory activity, cytotoxicity, and target specificity, four promising candidates emerged with 50% inhibitory concentration values in the 3 to 26 μM range. Molecular dynamics simulations of the two most potent candidates in their DOCK-predicted binding poses indicate that the majority of favorable interactions involve seven highly conserved residues that can be used to guide further inhibitor development and refinement targeting EBOV. The most recent Ebola virus disease outbreak, from 2014 to 2016, resulted in approximately 28,000 individuals becoming infected, which led to over 12,000 causalities worldwide. The particularly high pathogenicity of the virus makes paramount the identification and development of promising lead compounds to serve as inhibitors of Ebola infection. To limit viral load, the virus-host membrane fusion event can be targeted through the inhibition of the class I fusion glycoprotein of. In the current work, several promising small-molecule inhibitors that target the glycoprotein GP2 were identified through systematic application of structure-based computational and experimental drug design procedures.

Research Organization:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC02-98CH10886; 1531492
OSTI ID:
1626071
Journal Information:
Journal of Virology, Vol. 93, Issue 15; ISSN 0022-538X
Publisher:
American Society for MicrobiologyCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 10 works
Citation information provided by
Web of Science

References (110)

Implementation and evaluation of a docking-rescoring method using molecular footprint comparisons journal May 2011
SPFP: Speed without compromise—A mixed precision model for GPU accelerated molecular dynamics simulations journal February 2013
Docking Screens for Novel Ligands Conferring New Biology: Miniperspective journal March 2016
Phantom PAINS: Problems with the Utility of Alerts for P an- A ssay IN terference Compound S journal February 2017
Footprint-based identification of viral entry inhibitors targeting HIVgp41 journal April 2012
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation journal October 2002
Toremifene interacts with and destabilizes the Ebola virus glycoprotein journal June 2016
The Ecstasy and Agony of Assay Interference Compounds journal February 2017
Permanent Inhibition of Viral Entry by Covalent Entrapment of HIV gp41 on the Virus Surface journal August 2011
Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation journal July 2015
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study journal June 2017
Design, Synthesis, and Structure−Activity Relationship of a Novel Series of 2-Aryl 5-(4-Oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 Entry Inhibitors journal December 2009
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection journal June 2005
Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis journal November 2011
Comparison of simple potential functions for simulating liquid water journal July 1983
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald journal August 2013
DOCK 6: Impact of new features and current docking performance journal April 2015
Novel Small Molecule Entry Inhibitors of Ebola Virus journal July 2015
Structure-based identification of inhibitors targeting obstruction of the HIVgp41 N-heptad repeat trimer journal July 2017
Computer-Aided Approaches for Targeting HIVgp41 journal August 2012
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1 journal August 2011
ZINC ? A Free Database of Commercially Available Compounds for Virtual Screening. journal April 2005
Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor journal March 2018
Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications journal August 2016
The Ecstasy and Agony of Assay Interference Compounds journal February 2017
C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: Effects of conjugation to cholesterol and side chain–side chain crosslinking journal October 2013
Chemical and Structural Aspects of Ebola Virus Entry Inhibitors journal December 2014
Automated docking with grid-based energy evaluation journal May 1992
Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target journal December 1998
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules journal March 2017
Implementation of the Hungarian Algorithm to Account for Ligand Symmetry and Similarity in Structure-Based Design journal January 2014
UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
Identification of a Small-Molecule Entry Inhibitor for Filoviruses journal January 2011
Development of Indole Compounds as Small Molecule Fusion Inhibitors Targeting HIV-1 Glycoprotein-41 journal October 2011
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution journal March 1999
Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever journal November 2011
Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1 + Endolysosomes Is a Rate-Defining Step journal December 2014
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures journal June 2018
Potent neutralizing monoclonal antibodies against Ebola virus infection journal May 2016
Fifteen countries are at risk of Ebola outbreak, says WHO journal October 2014
Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: Stability and pH effects journal August 2011
Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes journal March 2011
Ebola Virus Entry: A Curious and Complex Series of Events journal April 2015
Strategies for lead discovery: Application of footprint similarity targeting HIVgp41 journal January 2014
Development of therapeutics for treatment of Ebola virus infection journal February 2015
COBALT: constraint-based alignment tool for multiple protein sequences journal March 2007
Biochemical and Functional Characterization of the Ebola Virus VP24 Protein: Implications for a Role in Virus Assembly and Budding journal February 2003
Enfuvirtide journal May 2003
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB journal July 2015
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection journal June 2016
Development of HIV Entry Inhibitors Targeted to the Coiled-Coil Regions of gp41 journal March 2000
Molecular docking based screening of predicted potential inhibitors for VP40 from Ebola virus [English] journal May 2015
The Intracellular Cargo Receptor ERGIC-53 Is Required for the Production of Infectious Arenavirus, Coronavirus, and Filovirus Particles journal November 2013
pH-REMD Simulations Indicate That the Catalytic Aspartates of HIV-1 Protease Exist Primarily in a Monoprotonated State journal October 2014
Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41 journal December 2015
Novel cyclo-peptides inhibit Ebola pseudotyped virus entry by targeting primed GP protein journal July 2018
Basic local alignment search tool journal October 1990
PubChem BioAssay: 2017 update journal November 2016
An Aggregation Advisor for Ligand Discovery journal August 2015
FAF-Drugs3: a web server for compound property calculation and chemical library design journal April 2015
In silico prediction of Ebola Zaire GP1,2 immuno-dominant epitopes for the Balb/c mouse journal October 2015
Mechanism of high-mannose N-glycan breakdown and metabolism by Bifidobacterium longum journal November 2022
PubChem Substance and Compound databases journal September 2015
Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41 journal March 2016
Grid-based molecular footprint comparison method for docking and de novo design: Application to HIVgp41 journal February 2013
Pharmacophore-Based Similarity Scoring for DOCK journal August 2014
VMD: Visual molecular dynamics journal February 1996
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data journal June 2013
Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity journal October 2016
High mortality in non-Ebola virus disease cases: need to provide timely and effective care journal October 2017
The Primed Ebolavirus Glycoprotein (19-Kilodalton GP1,2): Sequence and Residues Critical for Host Cell Binding journal January 2009
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection journal August 2011
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays journal April 2010
Development of Peptide and Small-Molecule HIV-1 Fusion Inhibitors that Target gp41 journal September 2010
Docking Validation Resources: Protein Family and Ligand Flexibility Experiments journal October 2010
Clinical Management of Ebola Virus Disease in the United States and Europe journal February 2016
Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry journal June 2016
Biological weapons: Bioterrorism: management of major biological agents journal September 2006
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity journal November 1995
Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists journal July 2015
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born journal April 2012
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening journal December 2004
A new player in the puzzle of filovirus entry journal April 2012
Vesicular Stomatitis Virus G Protein Acquires pH-Independent Fusion Activity during Transport in a Polarized Endometrial Cell Line journal December 1999
Comparison of multiple Amber force fields and development of improved protein backbone parameters journal November 2006
Development and testing of a general amber force field journal January 2004
Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection journal January 2018
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure journal April 1988
Ebola Virus Disease in West Africa — Clinical Manifestations and Management journal November 2014
A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity journal June 2014
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses journal October 2015
Structure-Based Identification of Small Molecule Antiviral Compounds Targeted to the gp41 Core Structure of the Human Immunodeficiency Virus Type 1 journal August 1999
Stepwise gating of the Sec61 protein-conducting channel by Sec63 and Sec62 journal January 2021
Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets: Designed Ebolavirus Prehairpin Intermediate Mimics journal October 2014
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies journal August 2015
Emergence of Zaire Ebola Virus Disease in Guinea journal October 2014
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site journal May 2016
Transient Mammalian Cell Transfection with Polyethylenimine (PEI) book January 2013
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors journal March 2009
Inhibition of heat-shock protein 90 reduces Ebola virus replication journal August 2010
N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion journal October 2004
Optimization of lentiviral vector production using polyethylenimine-mediated transfection journal November 2014
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM journal January 2015
Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus journal November 2018
Proteolysis of the Ebola Virus Glycoproteins Enhances Virus Binding and Infectivity journal October 2007
Ebolavirus glycoprotein structure and mechanism of entry journal November 2009
Cysteine Cathepsin Inhibitors as Anti-Ebola Agents journal February 2016
Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity journal January 2010
Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by the gp41 Core: Role of a Conserved Hydrophobic Cavity in Membrane Fusion journal October 1999
Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 journal April 1998

Cited By (1)


Figures / Tables (17)